Background: Head and neck cancers (HNCs) continue to remain a significant public health burden worldwide, causing significant mortality and morbidity despite significant clinical advances enabling their early diagnosis and treatment. Methods: We used data from the GLOBOCAN 2012, Cancer Incidence in Five Continents, World Health Organization Mortality Database and Surveillance, Epidemiology, and End Results programmes to describe the current epidemiology of HNCs. Results: Estimated age-standardised incidence/mortality rates for cancers of the lip and oral cavity among males and females (7.0/2.3 and 2.6/0.6 per 100,000 per annum) in more developed regions are higher compared to those in less developed regions (5.0/2.8 and 2.5/1.4 per 100,000 per annum). Similarly, the estimated rates for cancers of the tonsils and pharynx among males (7.5/2.5 per 100,000 per annum) and females (2.7/0.5 per 100,000 per annum) are reported to be the highest in Western Europe, whereas these rates for cancer of the larynx among males (7.9/4.0 per 100,000 per annum) and females (0.9/0.5 per 100,000 per annum) are reported to be the highest in the Caribbean. Cancer of the nasopharynx represents a significant HNC burden in the Asia-Pacific region and Northern Africa. Conclusion: The current and future estimated burden of HNCs is shifting to less developed regions which may be ill equipped to deal with this increasing burden. This needs urgent attention of policy makers through effective cancer control policy implementation with population-based interventions.

1.
Ferlay J, Soerjomataram I, Ervik M, et al: GLOBOCAN v1.0, cancer incidence and mortality worldwide. IARC Cancer Base No. 11. Lyon, International Agency for Research on Cancer, 2012. Available at http://globocan.iarc.fr (accessed October 19, 2015).
2.
van Oijen MG, Slootweg PJ: Oral field cancerization: carcinogen-induced independent events or micrometastatic deposits? Cancer Epidemiol Biomarkers Prev 2000;9:249-256.
3.
Byakodi R, Byakodi S, Hiremath S, et al: Oral cancer in India: an epidemiologic and clinical review. J Community Health 2012;37:316-319.
4.
Furness S, Glenny AM, Worthington HV, Pavitt S, Oliver R, Clarkson JE, et al: Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev 2010;9:CD006386.
5.
Polesel J, Talamini R, La Vecchia C, Levi F, Barzan L, Serraino D, et al: Tobacco smoking and the risk of upper aero-digestive tract cancers: a reanalysis of case-control studies using spline models. Int J Cancer 2008;122:2398-2402.
6.
Pelucchi C, Gallus S, Garavello W, Bosetti C, La Vecchia C: Cancer risk associated with alcohol and tobacco use: focus on upper aero-digestive tract and liver. Alcohol Res Health 2006;29:193-198.
7.
Ansary-Moghaddam A, Huxley RR, Lam TH, Woodward M: The risk of upper aero digestive tract cancer associated with smoking, with and without concurrent alcohol consumption. Mt Sinai J Med 2009;76:392-403.
8.
Chang ET, Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006;15:1765-1777.
9.
Anantharaman D, Gheit T, Waterboer T, Abedi-Ardekani B, Carreira C, McKay-Chopin S, et al: Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst 2013;105:536-545.
10.
Boeing H, Dietrich T, Hoffmann K, Pischon T, Ferrari P, Lahmann PH, et al: Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: the prospective EPIC-study. Cancer Causes Control 2006;17:957-969.
11.
Maruccia M, Onesti MG, Parisi P, Cigna E, Troccola A, Scuderi N: Lip cancer: a 10 year retrospective epidemiological study. Anticancer Res 2012;32:1543-1546.
12.
Antoniades DZ, Styanidis K, Papanayotou P, Trigonidis G: Squamous cell carcinoma of the lips in a northern Greek population. Evaluation of prognostic factors on 5-year survival rate - I. Eur J Cancer B Oral Oncol 1995;31B:333-339.
13.
Sankaranarayanan R: Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol 1990;69:325-330.
14.
Piemonte ED, Lazos JP, Brunotto M: Relationship between chronic trauma of the oral mucosa, oral potentially malignant disorders and oral cancer. J Oral Pathol Med 2010;39:513-517.
15.
Rosenquist K, Wennerberg J, Schildt EB, Bladstrom A, Goran Hansson B, Andersson G: Oral status, oral infections and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125:1327-1336.
16.
Gupta B, Johnson NW: Emerging and established global life-style risk factors for cancer of the upper aero-digestive tract. Asian Pac J Cancer Prev 2014;15:5983-5991.
17.
Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M, Macpherson LM: Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies. Int J Cancer 2008;122:2811-2819.
18.
Schmeisser N, Conway DI, McKinney PA, McMahon AD, Pohlabeln H, Marron M, et al: Life course social mobility and risk of upper aerodigestive tract cancer in men. Eur J Epidemiol 2010;25:173-182.
19.
Jayaprakash V, Natarajan KK, Moysich KB, Rigual NR, Ramnath N, Natarajan N, et al: Wood dust exposure and the risk of upper aero-digestive and respiratory cancers in males. Occup Environ Med 2008;65:647-654.
20.
Richiardi L, Corbin M, Marron M, Ahrens W, Pohlabeln H, Lagiou P, et al: Occupation and risk of upper aerodigestive tract cancer: the ARCAGE study. Int J Cancer 2012;130:2397-2406.
21.
Johnson NW, Warnakulasuriya S, Gupta PC, et al: Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 2011;23:237-246.
22.
Slootweg PJ, Eveson JW: Introduction: tumours of the oral cavity and oropharynx; in Barnes L, Eveson JW, Reichart P, Sidransky D (eds): World Health Organisation Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon, IARC, 2005, pp 166-167.
23.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-E386.
24.
Ferlay J, Bray F, Steliarova-Foucher E, Forman D: Cancer Incidence in Five Continents CI5plus. IARC Cancer Base No. 9. Lyon, International Agency for Research on Cancer, 2014. Available at http://ci5.iarc.fr/Default.aspx (accessed October 19, 2015).
25.
Surveillance Research Program: SEER*Stat software. National Cancer Institute. Available at http://seer.cancer.gov/seerstat (accessed October 13, 2015).
26.
World Health Organization: Number of cancer deaths, mortality database 2014. Available at http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html (accessed October 23, 2015).
27.
WHO Databank: Global Health Observatory (GHO) data 2014. Available at http://www.who.int/gho/en/ (accessed October 23, 2015).
28.
United Nations Population Division: World Population Prospects. The 2012 Revision. New York, United Nations, 2012. Available at http://esa.un.org/unpd/wpp/ (accessed October 25, 2015).
29.
Segi M: Cancer Mortality for Selected Sites in 24 Countries (1950-57). Sendai, Tohoku University of Medicine, 1960.
30.
Doll R, Payne P, Waterhouse JAH: Cancer Incidence in Five Continents. Geneva, Union Internationale Contre le Cancer, 1966.
31.
Development of an ‘Atlas of Cancer in India': Indian Council for Medical Research. Available at http://www.canceratlasindia.org.
32.
Gupta B, Johnson NW: Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One 2014;9:e113385.
33.
Sinha DN, Abdulkader RS, Gupta PC: Smokeless tobacco-associated cancers: a systematic review and meta-analysis of Indian studies. Int J Cancer 2015;138:1368-1379.
34.
Suba Z: Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res 2007;13:195-202.
35.
Hashibe M, Brennan P, Chuang SC, et al: Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2009;18:541-550.
36.
Lin YS, Jen YM, Wang BB, Lee JC, Kang BH: Epidemiology of oral cavity cancer in Taiwan with emphasis on the role of betel nut chewing. ORL J Otorhinolaryngol Relat Spec 2005;67:230-236.
37.
Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al: Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 2015;112:580-593.
38.
Islami F, Tramacere I, Rota M, Bagnardi V, Fedirko V, Scotti L, et al: Alcohol drinking and laryngeal cancer: overall and dose-risk relation - a systematic review and meta-analysis. Oral Oncol 2010;46:802-810.
39.
Johnson NW, Jayasekara P, Amarasinghe AA: Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. Periodontol 2000 2011;57:19-37.
40.
Hamaker ME, Smorenburg CH, Bun RJ, de Kuyper GT, van Munster BC, de Rooij SE, et al: Age-related differences in guideline adherence for head and neck cancer. J Geriatr Oncol 2012;3:329-336.
41.
Rettig EM, D'Souza G: Epidemiology of head and neck cancer. Surg Oncol Clin N Am 2015;24:379-396.
42.
Warnakulasuriya S, Mak V, Moller H: Oral cancer survival in young people in South East England. Oral Oncol 2007;43:982-986.
43.
Chaturvedi AK, Anderson WF, Lortet-Tieulent J, Curado MP, Ferlay J, Franceschi S, et al: Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 2013;31:4550-4559.
44.
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al: Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-4301.
45.
Marur S, D'Souza G, Westra WH, Forastiere AA: HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010;11:781-789.
46.
Lowy DR, Schiller JT: Reducing HPV-associated cancer globally. Cancer Prev Res (Phila) 2012;5:18-23.
47.
Simard EP, Torre LA, Jemal A: International trends in head and neck cancer incidence rates: differences by country, sex and anatomic site. Oral Oncol 2014;50:387-403.
48.
Parkin DM: The role of cancer registries in cancer control. Int J Clin Oncol 2008;13:102-111.
49.
Gupta B, Ariyawardana A, Johnson NW: Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. Int Dent J 2013;63:12-25.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.